Siri Dandu

Siri Dandu

About

Bioengineering, 2026
Engineering & Applied Sciences
Siri Dandu
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts

Presenter
Prishna Martinez
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts ​